Clinical Trials Browser

Withdrawn × NIH × Uterine Cervical Neoplasms × Clear all

NCT04411134 2020-07-15

E7 TCR T Cell Immunotherapy for High-Grade Cervical Intraepithelial Neoplasia

Phase 1 Withdrawn

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT03220009 2018-10-03

Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

Phase 2 Withdrawn

DermatologicGastrointestinalGynecologic

Uterine Cervical Neoplasms, Esophageal Neoplasms, Melanoma, Vaginal Neoplasms, Vulvar Neoplasms